Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoantigen-loaded autologous dendritic cell therapy for malignant tumors
jRCTc030210026Completed
- Start
- Apr 2021
- Modality
- Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of neoantigen-loaded autologous dendritic cells in cancer. Primary endpoint: Safety. Started Apr 2021; status: completed.
02
Drugs
neoantigen-loaded autologous dendritic cells
03
Conditions
cancer
Beyond the preview
Go deeper on jRCTc030210026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTc030210026.